 |
市場調查報告書
商品編碼
1460168
脫礦骨基質市場- 按產品類型（凝膠、油灰、海綿、纖維、糊劑）、應用（牙科、顱頜面、關節重建、脊柱融合）、最終用途（醫院、專科診所） - 全球預測， 2024 年- 2032 年Demineralized Bone Matrix Market - By Product Type (Gel, Putty, Sponge, Fiber, Paste), Application (Dental, Craniomaxillofacial, Joint Reconstruction, Spinal Fusion), End-use (Hospitals, Specialty Clinics) - Global Forecast, 2024 - 2032 |
||||||
由於全球骨科疾病發生率不斷上升，脫礦骨基質市場預計從 2024 年到 2032 年將以 4.9% 的複合CAGR擴張。人口老化、運動相關損傷和退化性骨疾病等因素增加了骨科手術對脫礦骨基質 (DBM) 產品的需求。 DBM 能夠促進骨折、脊椎融合和關節重建中的骨癒合和再生，因此越來越受到外科醫生的青睞。
此外，外科醫生依靠 DBM 提供的骨誘導特性來促進成功的骨修復。隨著骨科疾病盛行率的上升，對 DBM 的需求不斷增加，從而為行業參與者提供了潛在的成長機會。例如，2023 年10 月，總部位於爾灣的Biogennix 是一家骨生物學公司，致力於為骨融合手術創造、製造和銷售獨特的骨移植材料，推出了完全由脫礦質皮質纖維製成的新型OsteoSPAN纖維基質。
脫礦骨基質產業分為產品類型、應用、最終用途和地區。
根據產品類型，預計 2024 年至 2032 年光纖領域的市場規模CAGR將達到 4.6%。 DBM 纖維在各種骨科應用（例如脊椎融合和骨移植手術）中提供增強的操控性和多功能性。它們還提供骨再生的支架，促進新骨的形成以及與周圍組織的整合。外科醫生更喜歡 DBM 纖維，因為它易於使用並且能夠適應複雜的解剖結構。此外，這些纖維具有加速癒合過程的卓越骨誘導特性，也推動了它們的採用。
在應用方面，牙科領域的脫礦骨基質市場預計在2024年至2032年間將出現5.1%的成長率。這是由於DBM因其促進骨再生和提高種植成功率的能力而在牙科手術中廣泛使用費率。牙科手術，例如齒槽保留、上顎竇提升和牙周手術，受益於 DBM 的骨誘導特性，有助於骨癒合和整合。對植牙和口腔手術的需求不斷成長，加上牙齒疾病的盛行率上升，正在推動 DBM 在牙科領域的使用。
考慮到區域格局，亞太地區脫礦骨基質產業將在 2023 年產生可觀的收入，並預計到 2032 年CAGR為5.5%。這一成長是由於人口眾多且老齡化，加上該地區骨科和牙科疾病發病率的增加。地區。不斷成長的醫療支出正在為改善醫療基礎設施讓路。此外，政府促進先進醫療技術和研發投資的措施也有助於區域產業的擴張。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 骨科疾病的發生率上升
- 脊椎融合和牙科手術數量不斷增加
- 隨著人口的成長而增加患者基礎
- 去礦骨基質領域的技術進展
- 產業陷阱與挑戰
- 去礦骨基質成本高
- 成長動力
- 成長潛力分析
- 監管環境
- 技術景觀
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 競爭定位矩陣
- 戰略展望矩陣
第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年
- 主要趨勢
- 凝膠
- 油灰
- 海綿
- 纖維
- 貼上
- 其他產品類型
第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年
- 主要趨勢
- 牙科應用
- 顱顎面
- 關節重建
- 脊椎融合術
- 其他應用
第 7 章：市場估計與預測：按最終用途，2018 - 2032 年
- 主要趨勢
- 醫院
- 門診手術中心
- 專科診所
- 其他最終用戶
第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 9 章：公司簡介
- Exactech, Inc.
- Halma plc
- Hans Biomed Corporation Ltd
- Institut Straumann AG
- Johnson & Johnson
- Medtronic plc
- RTI Surgical, Inc.
- Seaspine Holdings Corporation
- Stryker Corporation
- Xtant Medical Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
Demineralized Bone Matrix Market is poised to expand at 4.9% CAGR from 2024 to 2032 due to the rising incidence of orthopedic conditions globally. Factors, such as increasing aging population, sports-related injuries, and degenerative bone diseases are contributing to the demand for demineralized bone matrix (DBM) products in orthopedic surgeries. The ability of DBM to promote bone healing and regeneration in fractures, spinal fusions, and joint reconstructions is surging its preference among surgeons.
Additionally, surgeons rely on the osteoinductive properties offered by DBM to facilitate successful bone repair. With the rising prevalence of orthopedic disorders, the demand for DBM is rising, thereby providing potential growth opportunities to the industry players. For instance, in October 2023, Irvine-based Biogennix, an osteobiologics firm that creates, manufactures, and markets unique bone graft materials for bone fusion surgeries, introduced the new OsteoSPAN Fiber Matrix, made entirely of demineralized cortical fibers.
The demineralized bone matrix industry is segmented into product type, application, end-use, and region.
Based on product type, the market size from the fiber segment is anticipated to record 4.6% CAGR from 2024-2032. DBM fibers offer enhanced handling and versatility in various orthopedic applications, such as spinal fusions and bone grafting procedures. They also provide a scaffold for bone regeneration, promoting new bone formation and integration with surrounding tissues. Surgeons prefer DBM fibers for their ease of use and ability to conform to complex anatomies. Additionally, the superior osteoinductive properties of these fibers to accelerate the healing process is fueling their adoption.
In terms of application, the demineralized bone matrix market from the dental segment is projected to witness 5.1% growth rate between 2024 and 2032. This is owing to the widespread use of DBM in dental surgeries for its ability to promote bone regeneration and enhance implant success rates. Dental procedures, such as socket preservation, sinus lifts, and periodontal surgeries benefit from the osteoinductive properties of DBM, aiding in bone healing and integration. The growing demand for dental implants and oral surgeries coupled with the rising prevalence of dental disorders is boosting the use of DBM in the dental field.
Given the regional landscape, the Asia Pacific demineralized bone matrix industry generated considerable revenue in 2023 and is set to exhibit 5.5% CAGR through 2032. The growth is due to the large and aging population, coupled with increasing incidences of orthopedic and dental conditions in the region. The rising healthcare expenditure is making way for improving healthcare infrastructure. Moreover, government initiatives for promoting advanced medical technologies and investments in R&D are contributing to the regional industry expansion.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of orthopedic disorders
- 3.2.1.2 Increasing number of spinal fusion and dental surgeries
- 3.2.1.3 Increasing patient base with growing population
- 3.2.1.4 Technological advancements in the field of demineralized bone matrix
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of demineralized bone matrix
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Gel
- 5.3 Putty
- 5.4 Sponge
- 5.5 Fiber
- 5.6 Paste
- 5.7 Other product types
Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Dental applications
- 6.3 Craniomaxillofacial
- 6.4 Joint reconstruction
- 6.5 Spinal fusion
- 6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers
- 7.4 Specialty clinics
- 7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Exactech, Inc.
- 9.2 Halma plc
- 9.3 Hans Biomed Corporation Ltd
- 9.4 Institut Straumann AG
- 9.5 Johnson & Johnson
- 9.6 Medtronic plc
- 9.7 RTI Surgical, Inc.
- 9.8 Seaspine Holdings Corporation
- 9.9 Stryker Corporation
- 9.10 Xtant Medical Holdings, Inc.
- 9.11 Zimmer Biomet Holdings, Inc.
